A receptor that cannabis latches onto in the brain could be a promising target for future mental health treatments. Experiencing chronic stress is known to leave people vulnerable to depression or ...

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? The results of studies in mice, headed by researchers at Université Laval, ...

The endocannabinoid system is the body’s system that regulates an array of other systems in the body. It works to maintain homeostasis by the use of receptors, cannabinoids, and metabolic pathways ...

When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? A protein that acts as a cannabinoid receptor and is present in the structure ...

Despite some evidence that cannabis reduces intraocular eye pressure from glaucoma, the ophthalmology community hasn’t embraced its use. One reason cited: The short duration of effect means a patient ...

Neuroscientist Rogier Min from the Amsterdam UMC has collaborated with Christiaan Levelt’s lab from the Netherlands Institute for Neuroscience and discovered how brain cells may react to cannabis, ...

Here at A3, we believe in equal opportunity. We recognize that saying we have an addiction problem is not the same as saying we have a drug use problem and that just because some people abuse ...

Despite the need, there are no FDA-approved medications to treat cannabis use disorder. AEF0117 is the first of a new pharmacologic class, type 1 cannabinoid receptor signaling-specific inhibitors ...

Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinical-stage biotechnology company focused on unlocking new therapeutic ...

A new study found that cannabis affects brain development by interacting with CB1 receptors on astrocytes. The findings indicate that disrupting CB1 receptor activity during development, such as via ...

BORDEAUX, France — Could AEF0117, a drug that has a novel mechanism of action in the brain, be the drug to fight cannabis addiction? Results from a phase 2a clinical trial that examined the efficacy ...